MEDICATION USE EVALUATION OF KETAMINE FOR SEDATION AND ANALGESIA IN MECHANICALLY VENTILATED PATIENTS

Document Type

Conference Proceeding

Publication Title

Critical Care MEdicine

Abstract

This was a multi-center, retrospective analysis of patients receiving ketamine as an adjunctive agent for sedation and analgesia compared to standard of care. Mechanically ventilated adult patients who received at least two continuous infusion sedative or analgesic agents from May 2020 to May 2021 were included. Patients receiving ketamine infusion as an adjunctive agent for at least six hours were included in the comparator group. The primary outcome evaluated was 28-day ventilator-free days. Secondary outcomes included impact on sedation and analgesic requirements, incidence of tachyarrhythmias, and increased secretions.

First Page

546

DOI

10.1097/01.ccm.0000910128.39777.c9

Publication Date

1-2023

Link to Full Text

Share

COinS